Search
for
Sort by
Research 91–120 of 1000+
- Lupus erythematosus: systemic and cutaneous manifestations
- Cutaneous manifestations associated with substance use disorders
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- 13. Wound Healing & Hair
- 6. Phototherapy, Photomedicine, and Pigmentary Disorders
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- ADVERSE EFFECTS OF OPIOID ANALGESIC DRUGS
- Anthelminthic drugs
- Aldesleukin
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Vaccines, adjuvants and autoimmunity
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Complementary Therapy with Traditional Chinese Medicine for Polycystic Ovarian Syndrome
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Synergistic Effects of Cinnamomum zeylanicum and Inositol on Metabolic and Hormonal Parameters in Women with Polycystic Ovary Syndrome
- Clinical aspects of the metabolic syndrome
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome